Published in Hepatology on August 01, 1994
delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A (1980) 5.12
Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis (1980) 4.28
The delta agent. Hepatology (1983) 3.72
Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol (1986) 3.63
Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children. Lancet (1992) 3.52
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron (1995) 3.08
Types of 'reticulin' antibodies detected in human sera by immunofluorescence. J Clin Pathol (1973) 2.98
Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immun (1984) 2.81
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia (2005) 2.67
Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol (1973) 2.59
The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. J Immunol (1980) 2.57
Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut (2001) 2.53
Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology (1982) 2.38
Influence of delta infection on severity of hepatitis B. Lancet (1982) 2.31
Incidence and significance of antibodies to delta antigen in hepatitis B virus infection. Lancet (1979) 2.29
Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers. Lancet (1980) 2.17
Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med (1983) 2.16
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. J Hepatol (2007) 2.12
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A (1991) 2.05
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Efficacy of amoxycillin plus clavulanic acid-based triple therapy for Helicobacter pylori eradication: a retrospective study. Panminerva Med (2010) 1.99
Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain. Mol Cell Biol (2000) 1.85
In vitro catenation and decatenation of DNA and a novel eucaryotic ATP-dependent topoisomerase. Cell (1980) 1.76
Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology (1986) 1.75
Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res (1989) 1.73
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. Br J Dermatol (2001) 1.70
Hepatic disorders associated with liver-kidney microsomal antibodies. Br Med J (1974) 1.64
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study. Ann Oncol (2009) 1.55
Chronic Helicobacter pylori infection and migraine: a case-control study. Headache (2001) 1.54
Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial. Hepatology (1998) 1.53
Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann Intern Med (1998) 1.53
Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial. Am J Gastroenterol (1999) 1.52
Clinicopathological features of genetically confirmed Danon disease. Neurology (2002) 1.51
Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology (1974) 1.50
Serological response to the hepatitis delta virus in hepatitis D. Lancet (1987) 1.50
Helicobacter pylori seroprevalence in cirrhotic patients with hepatitis B virus infection. Neth J Med (2000) 1.50
Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. Lancet (1982) 1.50
Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal. Am J Gastroenterol (2002) 1.49
Infection with the delta agent in chronic HBsAg carriers. Gastroenterology (1981) 1.48
Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis. J Infect Dis (1989) 1.48
Thalassaemia in Azerbaijan. J Med Genet (1994) 1.48
Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. Am J Epidemiol (1983) 1.47
IgM antibody against measles virus in patients with inflammatory bowel disease: a marker of virus-related disease? Eur J Gastroenterol Hepatol (1997) 1.47
Enzyme-linked immunosorbent assay for detection of antibody to the hepatitis B surface antigen-associated delta antigen. J Clin Microbiol (1981) 1.47
Fibrogenesis serum markers in patients with chronic hepatitis C treated with alpha-IFN. J Gastroenterol (1999) 1.44
A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology (1989) 1.43
Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients. J Hepatol (2001) 1.43
Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo score. Eur J Gastroenterol Hepatol (1997) 1.42
Template supercoiling by a chimera of yeast GAL4 protein and phage T7 RNA polymerase. Science (1990) 1.41
Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study. Panminerva Med (2008) 1.39
Mitochondrial DNA polymorphism in four Sardinian villages. Ann Hum Genet (1988) 1.39
Infliximab for treatment of steroid-refractory ulcerative colitis. Dig Liver Dis (2002) 1.39
Striking aminotransferase rise after chlorhexidine self-poisoning. Lancet (1982) 1.38
Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen:" clinical significance in delta infection. J Med Virol (1982) 1.38
Prevalence and risk factors for nosocomial infections in hospitals of the Veneto region, north-eastern Italy. Infection (2008) 1.37
Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology (1987) 1.35
Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology (2000) 1.34
Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses. Clin Exp Immunol (1974) 1.33
A genetic history of Italy. Ann Hum Genet (1988) 1.33
A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet (1998) 1.30
Intrahepatic localization of the surface (HBsAg) and core (HBcAg) antigenic determinants associated with hepatitis B virus in biopsy samples from patients with liver disease. Ric Clin Lab (1976) 1.27
A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol (1990) 1.24
Complement fixing hepatitis B core antigen immune complexes in the liver of patients with HBs antigen positive chronic disease. Gut (1976) 1.23
Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology (1989) 1.23
Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg (1997) 1.22
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications. J Viral Hepat (2007) 1.21
Experimental transmission of the delta agent to chimpanzees. Prog Clin Biol Res (1983) 1.21
Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone. Am J Pathol (1999) 1.21
Comparative mutational analysis of wild-type and stretched tRNA3(Leu) gene promoters. Proc Natl Acad Sci U S A (1987) 1.21
Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses (2000) 1.20
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. J Hepatol (2001) 1.20
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity. Mol Pharmacol (1999) 1.17
Perinatal transmission of the hepatitis B virus and of the HBV-associated delta agent from mothers to offspring in northern Italy. J Med Virol (1982) 1.16
An ultrastructural and immunohistochemical study on the delta antigen associated with the hepatitis B virus. J Pathol (1979) 1.16
Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence. Clin Microbiol Infect (2009) 1.16
The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology (1997) 1.16
Immunoperoxidase staining of the HBV-associated delta antigen in paraffinated liver specimens. Pathologica (1982) 1.16
A radioimmunoassay for HBcAg in the sera of HBsAg carriers: serum HBcAg, liver HBcAg immunofluorescence as markers of chronic liver disease. Gastroenterology (1981) 1.15
Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology (1998) 1.14
The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients. Aliment Pharmacol Ther (2000) 1.14
Separation of RNA transcription and processing activities from X. laevis germinal vesicles. Cell (1979) 1.14
Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. Clin Exp Immunol (1983) 1.13